Skip to main content
Signal8

Cannara Biotech Inc. (LOVFF)

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

Sector: Drug Manufacturers - Specialty & Generic

Industry: Drug Manufacturers - Specialty & Generic

Cannara Biotech Inc. logo

Cannara Biotech Inc.

OTC:LOVFFHealthcare
+0.42%$1.44
CLOSED
Mkt Cap$140.52M
EV$159.57M
Float47.39M
O/S97.85M
VOL108 sh
$ Vol$155
RVOL0.01×
Inst Own-
SI<0.1%
Net Cash/Sh-$0.19
EarningsNov 23 · in 6d
Dilution
Cannara Biotech Inc. logoOTC:LOVFFClosed$1.44+0.42%
Financials Summary
Revenue$75.12M
Net Income$9.15M
Total Assets$118.05M
Free Cash Flow$9.56M
Debt & Equity
Debt 29%
Equity 71%
Total Debt$29.11M
Total Equity$71.56M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:10Reverse split
    Feb 13, 202310 shares → 1
Balance Sheet Details
Assets$118.05M
Liabilities$46.5M
Accounts Receivable$9.87M
Accounts Payable$7.76M
Inventory$31.16M
PP&E (Net)$60.2M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-08-312024-08-312023-08-312022-08-312021-08-312020-08-312019-08-312018-08-31
Revenue$75.12M$57.22M$40.08M$25.09M$11.91M$1.79M$1.47M$303K
YoY Growth31.3%42.8%59.8%110.6%567.2%21.6%384.7%-
Cost of Revenue$42.07M$36.37M$21.02M$12.98M$4.71M$929K$283K$192K
Gross Profit$33.05M$20.85M$19.06M$12.11M$7.21M$857K$1.19M$111K
Gross Margin44.0%36.4%47.6%48.3%60.5%48.0%80.7%36.8%
Research and Development$498K$785K$722K$880K$1.33M$1.82M$0$0
Selling, General, and Administrative$16.22M$13.75M$9.46M$7.02M$5.11M$6.28M$7.95M$1.31M
Other$799K-$742K$554K$751K$17K$18K$0$0
Total Operating Expenses$17.52M$13.8M$10.74M$8.65M$7M$9.21M$8.34M$1.38M
Operating Income (EBIT)$15.54M$7.05M$8.32M$3.46M$180K-$8.37M-$7.16M-$1.27M
Operating Margin20.7%12.3%20.8%13.8%1.5%-468.6%-487.5%-420.0%
Interest Expense$2.64M$2.94M$3.17M$2.32M$1.1M$928K$1.06M$224K
Interest Income$197K$93K$168K$65K$37K$186K$476K$19K
Other Income (Expense)-$2.87M-$3.92M-$3.46M-$1.84M-$1.25M-$799K-$1.92M-$207K
Income Before Tax (EBT)$12.67M$3.14M$4.86M$1.61M-$1.07M-$9.17M-$9.08M-$1.48M
Income Tax Expense$3.51M-$1.37M$0$0$0$0$0$0
Net Income$9.15M$4.51M$4.86M$1.61M-$1.07M-$8.74M-$8.62M-$1.48M
Net Income Margin12.2%7.9%12.1%6.4%-9.0%-489.4%-587.3%-488.4%
Supplementary Data
EPS0.140.070.080.03-0.02-0.17-0.17-0.03
Diluted EPS0.140.070.080.03-0.02-0.17-0.17-0.03
Weighted Average OS92.37M91.52M89.30M87.67M76.52M71.33M70.68M69.38M
EBITDA$19.92M$10.62M$11.04M$5.88M$2.15M-$6.43M-$7.63M-$1.18M
EBITDA Margin26.5%18.6%27.5%23.4%18.0%-360.1%-519.5%-389.1%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-08-312024-08-312023-08-312022-08-312021-08-312020-08-312019-08-312018-08-31
Assets
Current Assets
Cash and Cash Equivalents$10.05M$4.63M$2.99M$8.48M$5.71M$5.44M$18.55M$9.03M
Short-Term Investments$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$10.05M$4.63M$2.99M$8.48M$5.71M$5.44M$18.55M$9.03M
Accounts Receivable$9.87M$9.13M$7.42M$6.03M$2.08M$40K$102K$154K
Inventory$31.16M$28.05M$23.64M$13.29M$5.19M$1.57M$131K-$256K
Other Current Assets$4.77M$5.42M$2.14M$0$0$176K$625K$0
Total Current Assets$57.51M$47.23M$36.19M$28.69M$13.47M$7.37M$19.48M$9.44M
Long-Term Assets
Property, Plant & Equipment Net$60.2M$59.53M$62.61M$59.03M$50.62M$30.61M$27.48M$9.68M
Goodwill$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$114K$197K$0
Long-Term Investments$0$0$0$0$51K$51K$0$0
Deferred Tax Assets$0$1.37M$0$0$0-$51K$0$0
Other Long-Term Assets$341K$179K$273K$207K$277K$297K$514K$1.09M
Total Long-Term Assets$60.54M$61.07M$62.88M$59.24M$50.94M$31.02M$28.19M$10.76M
Other Assets$0$0$0$0$0$0$0$0
Total Assets$118.05M$108.31M$99.07M$87.93M$64.42M$38.4M$47.67M$20.2M
Liabilities
Current Liabilities
Accounts Payable$7.76M$6.89M$6.22M$6.2M$4.33M$1.93M$3.24M$764K
Short-Term Debt$9.11M$6.46M$4.18M$1.38M$212K$211K$0$0
Current Income Tax Payable$0$5.26M$736K$224K$0$0$0$0
Current Unearned Revenue$93K$94K$113K$32K$29K$35K$0-$51K
Other Current Liabilities$0$0$0$542K$50K$112K$230K$0
Total Current Liabilities$23.94M$18.9M$14.83M$8.3M$4.78M$2.43M$3.56M$815K
Long-Term Liabilities
Long-Term Debt$19.72M$26.92M$27.75M$32.33M$14.11M$8.39M$8.77M$8.76M
Long-Term Unearned Revenue$615K$661K$600K$572K$494K$357K$0$0
Long-Term Deferred Tax Liabilities$2.15M$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$53K$0$0
Total Long-Term Liabilities$22.56M$27.84M$28.42M$32.91M$14.75M$9.11M$9.16M$9.07M
Other Liabilities$0$0$0$0$0$0$0$0
Total Liabilities$46.5M$46.74M$43.25M$41.22M$19.54M$11.54M$12.72M$9.88M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$1.27M
Common Stock$62.84M$61.97M$62.16M$58.31M$58.25M$40.85M$38.45M$11.1M
Retained Earnings$125K-$9.03M-$13.54M-$18.41M-$20.02M-$18.95M-$10.1M-$1.48M
Comprehensive Income & Other$0$0-$49K$11K$70K$32K-$7K-$1.27M
Other Stockholders' Equity$8.59M$8.63M$7.2M$6.82M$6.66M$4.96M$4.67M$701K
Total Equity$71.56M$61.57M$55.82M$46.72M$44.88M$26.86M$33.02M$10.32M
Minority Interest$0$0$0$0$0$0$1.93M$0
Total Liabilities and Equity$118.05M$108.31M$99.07M$87.93M$64.42M$38.4M$45.74M$20.2M
Supplementary Data
Total Debt$29.11M$33.83M$32.05M$33.87M$14.63M$9.05M$9.26M$9.12M
Net Debt$19.05M$29.19M$29.06M$25.39M$8.92M$3.61M-$9.3M$89K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-08-312024-08-312023-08-312022-08-312021-08-312020-08-312019-08-312018-08-31
Operating Activities
Net Income$9.15M$4.51M$4.86M$1.61M-$1.07M-$9.17M-$9.08M-$1.48M
Depreciation & Amortization$4.68M$4.45M$3.46M$2.74M$2.12M$1.81M$396K$77K
Deferred Income Tax$3.51M-$1.37M$0$0$46K$34K$0$0
Stock-Based Compensation$835K$1.38M$1.37M$245K$232K$547K$1.53M$195K
Changes in Working Capital:
  Accounts Receivable-$156K-$1.44M-$1.43M-$3.97M-$1.97M$20K$52K-$256K
  Inventory-$5.93M-$2.78M-$5.83M-$5.76M-$2.34M-$1.15M-$131K$0
  Accounts Payable$370K$1.55M$0$0$1.53M$651K$367K$764K
  Other Working Capital$1.3M$922K-$629K$16K$115K$275K-$110K$530K
Total Working Capital Change-$4.41M-$1.75M-$7.89M-$9.71M-$2.67M-$203K$179K$274K
Other Non-Cash Items$240K$257K$2.34M$857K-$118K$452K$1.79M$224K
Net Cash from Operating$14.01M$7.48M$4.14M-$4.26M-$1.47M-$6.53M-$5.19M-$807K
Investing Activities
Capital Expenditures-$4.45M-$5.23M-$6.92M-$10.83M-$21.75M-$6.17M-$15.62M-$10.49M
Acquisitions$0$0$0$0$152K$352K$682K$0
Purchases of Investments$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0
Other Investing Activities$286K$1.6M$281K$85K$19K-$168K-$207K-$1.45M
Net Cash from Investing-$4.17M-$3.63M-$6.63M-$10.74M-$21.58M-$5.99M-$15.15M-$10.49M
Financing Activities
Debt Repaid$2.16M$1.56M$1.57M-$19.31M-$7.06M$394K$165K-$8.79M
Common Stock Issuance$0$0$0$0$17.01M$488K$32.36M$12.37M
Common Stock Repurchases$0-$194K-$262K$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0
Other Financing Activities-$2.62M-$2.73M-$1.1M-$1.48M-$792K-$247K-$2.33M-$820K
Net Cash from Financing-$4.43M-$2.2M-$2.94M$17.83M$23.28M-$640K$29.86M$20.33M
Forex Effect$0$0-$59K-$59K$41K$39K-$12K$0
Net Change in Cash$5.42M$1.64M-$5.49M$2.77M$272K-$13.11M$9.52M$9.03M
Supplementary Data
Operating Cash Flow$14.01M$7.48M$4.14M-$4.26M-$1.47M-$6.53M-$5.19M-$807K
Capital Expenditure-$4.45M-$5.23M-$6.92M-$10.83M-$21.75M-$6.17M-$15.62M-$10.49M
Free Cash Flow$9.56M$2.25M-$2.78M-$15.08M-$23.22M-$12.7M-$20.81M-$11.3M
Cash at Beginning$4.63M$2.99M$8.48M$5.71M$5.44M$18.55M$9.03M$0
Cash at End$10.05M$4.63M$2.99M$8.48M$5.71M$5.44M$18.55M$9.03M